Characterization of intestinal immune responses in generalized human and murine lipodystrophy

Autor/innen

  • Marilena Letizia
  • Toka Omar
  • Patrick Weidner
  • Manuel O. Jakob
  • Inka Freise
  • Susanne M. Krug
  • Britt-Sabina Löscher
  • Elisa Rosati
  • Benedikt Obermayer
  • Reyes Gamez-Belmonte
  • Julia Hecker
  • Jörn-Felix Ziegler
  • Benjamin Weixler
  • Patrick Asbach
  • Desiree Kunkel
  • Michael Stumvoll
  • Konstanze Miehle
  • Christoph Becker
  • Christoph S.N. Klose
  • Rainer Glauben
  • Dieter Beule
  • Anja A Kühl
  • Thomas Conrad
  • Frank Tacke
  • Stefan Wirtz
  • Andre Franke
  • Ashley D. Sanders
  • Britta Siegmund
  • Carl Weidinger

Journal

  • Journal of Clinical Investigation

Quellenangabe

  • J Clin Invest 136 (6): e192322

Zusammenfassung

  • Acquired generalized lipodystrophy (AGL) is a rare metabolic disorder frequently associated with autoimmunity. Its etiology is incompletely understood, and the effect of adipose tissue loss on intestinal inflammation in AGL remains unclear. Using mass cytometry and single-cell RNA-seq, we observed an oligoclonal expansion of T cells in the periphery and inflamed intestine in a patient with AGL and Crohn's disease (AGLCD). To explore if loss of adipose tissue triggers lymphoproliferation, we studied lipodystrophic mice as a model for AGL. Unexpectedly, lipodystrophic mice did not show T cell expansion, were protected from colitis, and displayed a defect in the development of proinflammatory T cells, which could be reversed by allogeneic fat transplantations, indicating that clonal T cell expansion in AGLCD is not primarily caused by lipodystrophy. Instead, gene sequencing revealed a T cell-intrinsic de novo neuroblastoma RAS viral oncogene homolog (NRAS) mutation, implicating somatic mosaicism as a facilitator of clonal T cell expansion and intestinal inflammation in AGLCD.


DOI

doi:10.1172/jci192322